Philippe Ledru - 05 Feb 2024 Form 4 Insider Report for Aptose Biosciences Inc. (APTOF)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APTO	Employee Stock Option (Right to Buy)	Award	$0	+11,000		$0.000000	11,000	05 Feb 2024	Common Shares	11,000	$2.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	50% of the options vest on February 5, 2025, with the remaining options vesting as follows: 1/3 on February 5, 2026; 1/3 on February 5, 2027; and 1/3 on February 5, 2028.